FDA Inspection 802081 — Merck Serono S.p.A.

Merck Serono S.p.A. — FEI 3003581732

The FDA completed an inspection of Merck Serono S.p.A. on September 25, 2012 in Modugno. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 25, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Modugno (Italy)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
139521 CFR 211.103Actual vs. theoretical yields not determined
145121 CFR 211.113(b)Procedures for sterile drug products
163021 CFR 211.130(b)Unlabeled filled containers controls
431521 CFR 211.84(d)(2)Testing Each Component for Conformity with Specs